MedTrace Logo

Myeloid Suppressors in Inflammation

NCT01224223 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2012-06-28

No results posted yet for this study

Summary

Myeloid-derived suppressor cells (MDSC) have been studied for their ability to suppress T cell responses in vivo and in vitro. As a result, MDSC can regulate cellular responses to chronic inflammatory conditions such as cancer, leading to the induction of tolerance and, ultimately, tumor escape from immune surveillance.

Conditions

Sponsors & Collaborators

  • University of South Florida

    lead OTHER

Principal Investigators

  • Richard Lockey, MD · USF Asthma, Allergy and Immunology CRU

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01224223 on ClinicalTrials.gov